BioCryst - BCRX Company Short-Term Debt

Graphic logo of BioCryst (BCRX)

BioCryst (BCRX) ensures a stable cash flow driven by the loyalty of patients taking Orladeyo. The business model relies on creating affordable tablet forms of drugs for the therapy of orphan diseases, which simplifies distribution. This chart demonstrates the dynamics of the debt profile, which currently stands at 0.00. The company's innovative products are successfully displacing injectable treatments in the global market.

BCRX (BioCryst Pharmaceuticals, Inc.) Company Short-Term Debts history from 07/04/2022 to 10/28/2026

BioCryst Corp - analytical breakdowns and key metrics (BCRX)

- price and consensus price forecast:
Price Chart BioCryst Pharmaceuticals|BCRX - Fair Value Consensus
- market capitalization data:
Market Value BioCryst Pharmaceuticals|BCRX - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share BioCryst|BCRX - Book Capitalization|Market Cap to Net Assets Ratio biocryst.com|BCRX - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital BioCryst|BCRX - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity BioCryst|BCRX - Company Total Debt|Debt to Book Capitalization Ratio BioCryst Pharmaceuticals|BCRX - Company Long-Term Liabilities|Company Current Liabilities BioCryst
Fundamental company valuation:BioCryst Pharmaceuticals - BCRX
Product sample of BioCryst

Investors assess fundamental risks by analyzing liquidity and the company's ability to service current liabilities. For BioCryst (BCRX), which delegates production to contract manufacturing organizations (CMOs), controlling short-term financing is critical for supply stability. This short-term loan capital aggregates all debts with a maturity of up to one year, currently totaling 0.00. An increase in this metric signals a heightened reliance on external borrowings, while the stability of the metric confirms the financial resilience of the business model.

Competitor analysis

Company Short-Term Debt argenx (ARGX)|BNTX: Company Short-Term Loans and Borrowings|ABVX (Abivax) - Company Short-Term Debt|ADMA Corp (ADMA) - Company Current Liabilities|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com (IMVT)|Kiniksa (KNSA) - Company Current Liabilities|Company Short-Term Loans and Borrowings Grifols SA (GRFS)|Company Short-Term Debts ADPT|Celldex Corp - Short-Term Debt Volume|AUPH: Company Short-Term Debt|VERA: Company Current Liabilities|DNTH (Dianthus Therapeutics, Inc.) - Company Short-Term Debt|Company Current Liabilities Pharvaris NV|ABCL (AbCellera Biologics) - Company Current Liabilities|Company Short-Term Debts TRML|Company Short-Term Debt Precigen, Inc. PGEN|Company Short-Term Indebtedness pharming.com (PHAR)|NKTR: Company Short-Term Debts|Short-Term Debt Upstream Bio, Inc. UPB|ZBIO - Company Short-Term Debts|IMNM - Company Short-Term Debt|Gossamer Bio, Inc. - Company Short-Term Debts|KALV (kalvista.com) - Short-Term Debt Volume|Company Short-Term Debt SEPN (Septerna)|Short-Term Debt Pieris Pharma|Company Short-Term Debts SVRA (Savara Corp)|Company Current Liabilities RIGL (Rigel Corp)|Company Short-Term Debt AnaptysBio, Inc.|ATXS - Company Short-Term Loans and Borrowings|ENGN (enGene) - Company Current Liabilities|RAPT: Short-Term Debt|aerovatetx.com - Company Short-Term Debt|Short-Term Debt Volume Aclaris Therapeutics, Inc|Kyverna Therapeutics (KYTX) - Company Current Liabilities|Amount of Current Liabilities tizianalifesciences.com|Company Short-Term Debts Cabaletta Bio (CABA)|Company Short-Term Debt Ventyx Biosciences Inc. (VTYX)|Theratechnologies Inc - Company Short-Term Debts|Avalo Therapeutics Inc - Company Current Liabilities|Company Short-Term Debt Eledon Pharmaceuticals (ELDN)|agenusbio.com (AGEN) - Company Short-Term Loans and Borrowings|Company Current Liabilities Climb Bio|ZURA (zurabio.com) - Company Short-Term Indebtedness|Company Short-Term Debt aTyr ATYR|Current Liabilities Adagene Corp|ImageneBio Inc (IMA) - Company Short-Term Debts|Company Short-Term Loans and Borrowings shattucklabs.com (STTK)|Company Short-Term Debts EQ (Equillium)|Connect Biopharma Holdings - Company Short-Term Debts|Company Short-Term Debt Immunic Inc (IMUX)|ATRA: Company Short-Term Loans and Borrowings|IFRX (inflarx.de) - Company Short-Term Debt|x4pharma.com (XFOR) - Company Current Liabilities|ACET (Adicet Bio Inc.) - Company Short-Term Debts|Company Short-Term Debts Celularity Corp (CELU)|INmune Bio Corp (INMB) - Company Current Liabilities|Company Short-Term Loans and Borrowings Barinthus Biotherapeutics Corp (BRNS)|Company Short-Term Debts KZR|sabbiotherapeutics.com - Short-Term Debt Volume|AKTX: Company Short-Term Debt|ENLV: Company Current Liabilities|QTTB (q32bio.com) - Company Short-Term Debt|Company Current Liabilities GeoVax Corp|EDSA (Edesa Biotech, Inc.) - Company Current Liabilities|Company Short-Term Debts IBIO|Company Short-Term Debt Carisma Therapeutics CARM|Company Short-Term Indebtedness XTL Biopharmaceuticals Ltd (XTLB)|BOLT: Company Short-Term Debts|Short-Term Debt HCW Biologics, Inc. HCWB|APVO - Company Short-Term Debts|AIM - Company Short-Term Debt|aditxt.com - Company Short-Term Debts|GRI (GRI Bio Inc) - Short-Term Debt Volume|Company Short-Term Debt XRTX (XORTX)|Short-Term Debt Vyome Therapeutics|Company Short-Term Debts REVB (Revelation Biosciences)|Company Current Liabilities INDP (indaptusrx.com)|Company Short-Term Debt Scinai Immunotherapeutics Ltd.|CALI - Company Short-Term Loans and Borrowings|AFMD (Affimed Therapeutics) - Company Current Liabilities|ALLK: Short-Term Debt|hookipapharma.com - Company Short-Term Debt|Short-Term Debt Volume IGM Biosciences|iTeos Therapeutics, Inc. (ITOS) - Company Current Liabilities|Amount of Current Liabilities Ocean Biomedical Inc|Company Short-Term Debts TC BioPharm (Holdings) PLC (TCBP)|Company Short-Term Debt Third Harmonic Bio Inc (THRD)